Reversal of aggregation using β-breaker dipeptide containing peptides: Application to Aβ(1-40) self-assembly and its inhibition.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4030796)

Published in ACS Chem Neurosci on April 03, 2014

Authors

Krishna Chaitanya Nadimpally1, Ashim Paul, Bhubaneswar Mandal

Author Affiliations

1: Laboratory of Peptide and Amyloid Research, Department of Chemistry, Indian Institute of Technology Guwahati , Assam-781039, India.

Articles cited by this

Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87

Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19

A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci (1993) 7.92

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 7.16

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA (2000) 6.55

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci (1999) 3.92

Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol (1994) 3.19

Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem (1996) 2.93

Solubilization and disaggregation of polyglutamine peptides. Protein Sci (2001) 2.00

Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int J Pept Protein Res (1987) 1.62

Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. J Mol Biol (2002) 1.47

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci U S A (1992) 1.41

Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry (1999) 1.40

Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid. Angew Chem Int Ed Engl (2004) 1.10

Self-assembled monolayers from a designed combinatorial library of de novo beta-sheet proteins. Proc Natl Acad Sci U S A (2001) 1.03

Switch peptides in statu nascendi: induction of conformational transitions relevant to degenerative diseases. Angew Chem Int Ed Engl (2004) 1.00

Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly. ACS Chem Neurosci (2012) 0.96

Inhibition of protein misfolding and aggregation by small rationally-designed peptides. Curr Pharm Des (2006) 0.87

Switch-peptides: design and characterization of controllable super-amyloid-forming host-guest peptides as tools for identifying anti-amyloid agents. Chembiochem (2008) 0.79

Inhibition of amyloid peptide fragment Aβ25-35 fibrillogenesis and toxicity by N-terminal β-amino acid-containing esapeptides: is taurine moiety essential for in vivo effects? Chem Biol Drug Des (2011) 0.79